This inventor holds 2 USPTO granted patents. Top assignees: Brandeis University, The Brigham and Women's Hospital, Inc., University of Georgia Research Foundation Inc. Active years: 2016-2018.
Company Filing History:
2 out of 268 
2 out of 1,422 
1 out of 870 Years Active: 2016-2018
Title: Innovations by Suresh K Gorla
Introduction
Suresh K Gorla is an accomplished inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal microbial infections. With a total of two patents to his name, Gorla's work focuses on developing compounds that can effectively inhibit specific enzymes related to parasitic infections.
Latest Patents
Gorla's latest patents include innovative compounds and methods for treating mammalian gastrointestinal microbial infections. These patents describe compounds and their pharmaceutically acceptable salts and prodrugs, which serve as inhibitors of IMPDH. In certain embodiments, these compounds selectively inhibit a parasitic IMPDH while sparing the host's enzyme. The patents also detail pharmaceutical compositions that incorporate these compounds, along with methods for treating various parasitic and bacterial infections in mammals. Furthermore, the compounds can be utilized alone or in combination with other therapeutic agents, such as anti-virals, anti-inflammatory agents, antimicrobials, and immunosuppressants.
Career Highlights
Throughout his career, Suresh K Gorla has worked with prestigious institutions, including Brandeis University and The Brigham and Women's Hospital, Inc. His research has significantly advanced the understanding and treatment of gastrointestinal infections, showcasing his dedication to improving health outcomes.
Collaborations
Gorla has collaborated with notable colleagues, including Lizbeth K Hedstrom and Gregory D Cuny. These partnerships have contributed to the development of his innovative solutions in the pharmaceutical field.
Conclusion
Suresh K Gorla's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work in developing targeted treatments for gastrointestinal infections is a testament to his innovative spirit and dedication to improving health.